# Correction: Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer

**Authors:** Anna van der Voort, Kay J. J. van der Hoogt, Ronni Wessels, Robert-Jan Schipper, Jelle Wesseling, Gabe S. Sonke, Ritse M. Mann

PMC · DOI: 10.1007/s00330-024-11008-8 · European Radiology · 2024-08-13

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11914221/full.md

---
Source: https://tomesphere.com/paper/PMC11914221